ACLIDINIUM

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C26H30NO4S2
Molecular Weight	484.651
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	1

SHOW SMILES / InChI

Structure of ACLIDINIUM

Structure Search

SMILES

OC(C(=O)O[C@H]1C[N+]3(CCCOC2=CC=CC=C2)CCC1CC3)(C4=CC=CS4)C5=CC=CS5

InChI

InChIKey=ASMXXROZKSBQIH-VITNCHFBSA-N

InChI=1S/C26H30NO4S2/c28-25(26(29,23-9-4-17-32-23)24-10-5-18-33-24)31-22-19-27(14-11-20(22)12-15-27)13-6-16-30-21-7-2-1-3-8-21/h1-5,7-10,17-18,20,22,29H,6,11-16,19H2/q+1/t20?,22-,27?/m0/s1

HIDE SMILES / InChI

Molecular Formula	C26H29NO4S2
Molecular Weight	483.643
Charge	0
Count

Stereochemistry	EPIMERIC
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:34:29 UTC 2023` Edited by `admin` on `Fri Dec 15 15:34:29 UTC 2023`
Record UNII	K17VY42F6C
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ACLIDINIUM

Common Name

English

Aclidinium [WHO-DD]

Common Name

English

(3R)-3-(2-HYDROXY(DI-2-THIENYL)ACETOXY)-1-(3-PHENOXYPROPYL)-1-AZONIABICYCLO(2.2.2)OCTANE

Systematic Name

English

ACLIDINIUM [VANDF]

Common Name

English

ACLIDINIUM CATION

Common Name

English

ACLIDINIUM ION

Common Name

English

1-AZONIABICYCLO(2.2.2)OCTANE, 3-((HYDROXYDI-2-THIENYLACETYL)OXY)-1-(3-PHENOXYPROPYL)-, (3R)-

Systematic Name

English

Classification Tree Code System Code

EMA ASSESSMENT REPORTS

BRIMICA GENUAIR ( AUTHORIZED: PLUMONARY DISEASE, CRONIC OBSTRUCTIVE)

Created by admin on Fri Dec 15 15:34:29 UTC 2023 , Edited by admin on Fri Dec 15 15:34:29 UTC 2023

WHO-ATC

R03BB05

Created by admin on Fri Dec 15 15:34:29 UTC 2023 , Edited by admin on Fri Dec 15 15:34:29 UTC 2023

NDF-RT

N0000175574

Created by admin on Fri Dec 15 15:34:29 UTC 2023 , Edited by admin on Fri Dec 15 15:34:29 UTC 2023

NCI_THESAURUS

C29704

Created by admin on Fri Dec 15 15:34:29 UTC 2023 , Edited by admin on Fri Dec 15 15:34:29 UTC 2023

WHO-ATC

R03AL05

Created by admin on Fri Dec 15 15:34:29 UTC 2023 , Edited by admin on Fri Dec 15 15:34:29 UTC 2023

Code System Code Type Description

DAILYMED

K17VY42F6C

Created by admin on Fri Dec 15 15:34:29 UTC 2023 , Edited by admin on Fri Dec 15 15:34:29 UTC 2023

PRIMARY

SMS_ID

100000135703

Created by admin on Fri Dec 15 15:34:29 UTC 2023 , Edited by admin on Fri Dec 15 15:34:29 UTC 2023

PRIMARY

CAS

727649-81-2

Created by admin on Fri Dec 15 15:34:29 UTC 2023 , Edited by admin on Fri Dec 15 15:34:29 UTC 2023

PRIMARY

PUBCHEM

11434515

Created by admin on Fri Dec 15 15:34:29 UTC 2023 , Edited by admin on Fri Dec 15 15:34:29 UTC 2023

PRIMARY

EPA CompTox

DTXSID00223070

Created by admin on Fri Dec 15 15:34:29 UTC 2023 , Edited by admin on Fri Dec 15 15:34:29 UTC 2023

PRIMARY

DRUG BANK

DB08897

Created by admin on Fri Dec 15 15:34:29 UTC 2023 , Edited by admin on Fri Dec 15 15:34:29 UTC 2023

PRIMARY

LACTMED

Aclidinium

Created by admin on Fri Dec 15 15:34:29 UTC 2023 , Edited by admin on Fri Dec 15 15:34:29 UTC 2023

PRIMARY

IUPHAR

7449

Created by admin on Fri Dec 15 15:34:29 UTC 2023 , Edited by admin on Fri Dec 15 15:34:29 UTC 2023

PRIMARY

EVMPD

SUB71686

Created by admin on Fri Dec 15 15:34:29 UTC 2023 , Edited by admin on Fri Dec 15 15:34:29 UTC 2023

PRIMARY

WIKIPEDIA

Aclidinium

Created by admin on Fri Dec 15 15:34:29 UTC 2023 , Edited by admin on Fri Dec 15 15:34:29 UTC 2023

PRIMARY

RXCUI

1303098

Created by admin on Fri Dec 15 15:34:29 UTC 2023 , Edited by admin on Fri Dec 15 15:34:29 UTC 2023

PRIMARY

RxNorm

NCI_THESAURUS

C79894

Created by admin on Fri Dec 15 15:34:29 UTC 2023 , Edited by admin on Fri Dec 15 15:34:29 UTC 2023

PRIMARY

FDA UNII

K17VY42F6C

Created by admin on Fri Dec 15 15:34:29 UTC 2023 , Edited by admin on Fri Dec 15 15:34:29 UTC 2023

PRIMARY

Related Record Type Details


					QQ0IJ5P4GV

MUSCARINIC ACETYLCHOLINE RECEPTOR M5

TARGET -> INHIBITOR

Qualification:

Ki

Amount:


					W3JX5KZ4V2

MUSCARINIC ACETYLCHOLINE RECEPTOR M3

TARGET -> INHIBITOR

Qualification:

Ki

Amount:


					8HOL4T03PN

MUSCARINIC ACETYLCHOLINE RECEPTOR M4

TARGET -> INHIBITOR

Qualification:

Ki

Amount:


					U87RX375T5

MUSCARINIC ACETYLCHOLINE RECEPTOR M2

TARGET->ANTAGONIST

Qualification:

Ki

Amount:


					UQW7UF9N91

ACLIDINIUM BROMIDE

SALT/SOLVATE -> PARENT

Amount:


					K17VY42F6C

EXCRETED UNCHANGED

Qualification:

URINE

Amount:


					V23K99CV7G

MUSCARINIC ACETYLCHOLINE RECEPTOR M1

TARGET -> INHIBITOR

Qualification:

Ki

Amount:

Related Record Type Details


					996D1Q4IM0

LAS-34823

METABOLITE -> PARENT

Comments:

in healthy subjects

Interaction Type:

MAJOR

Qualification:

FECAL; PLASMA; URINE

Amount:


					RI3X2J9148

DI-2-THIENYLGLYCOLIC ACID

METABOLITE -> PARENT

Interaction Type:

MAJOR

Qualification:

FECAL; PLASMA

Amount:


					723A77PV2M

2-THIOPHENEGLYOXYLIC ACID

METABOLITE -> PARENT

Amount:


					XD8V5ZR49L

1-AZONIABICYCLO(2.2.2)OCTANE, 3-HYDROXY-1-(3-(4-HYDROXYPHENOXY)PROPYL)-, LABELED WITH CARBON-14, (3R)-

METABOLITE -> PARENT

Amount:

Related Record Type Details


					K17VY42F6C

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Biological Half-life	PHARMACOKINETIC

Tmax	PHARMACOKINETIC

Volume of Distribution	PHARMACOKINETIC